<?xml version="1.0" encoding="UTF-8"?>
<ref id="B60-ijms-21-09049">
 <label>60.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nadal</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Del Río</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Casano</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Palomares</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ferreiro-Vera</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Navarrete</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sánchez-Carnerero</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Cantarero</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Bellido</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity</article-title>
  <source>Br. J. Pharmacol.</source>
  <year>2017</year>
  <volume>174</volume>
  <fpage>4263</fpage>
  <lpage>4276</lpage>
  <pub-id pub-id-type="doi">10.1111/bph.14019</pub-id>
  <pub-id pub-id-type="pmid">28853159</pub-id>
 </element-citation>
</ref>
